Skip to Main Content
In Depth

Yale Ob/Gyn Faculty Present the Latest in Gynecologic Oncology at Memorial Conference

1 Minute Read

It was a day of learning and a day of presentations, but also a day to remember a giant in Ob/Gyn - Peter E. Schwartz, MD, who was a departmental and world leader in GynOnc for nearly 50 years. He passed away on October 20.

The 39th Annual Ella T. Grasso Memorial Conference in Gynecologic Oncology was held at Yale West Campus on Wednesday, Nov. 6, hosted by Yale Cancer Center and Smilow Cancer Hospital.

As each presenter came up to deliver their talk, they first took a few minutes to share how Schwartz had impacted them personally and professionally. In addition, Elena Ratner, MD, MBA, gave Schwartz’s wife, Arlene - who was in attendance - the original proclamation Schwartz had received years ago from the State of Connecticut.

In Photos: the Yale Cancer Center and Smilow Cancer Hospital's 39th Annual Ella T. Grasso Memorial Conference in Gynecologic Oncology

The conference agenda included the following.

Session 1, on General Health Cervical Malignancies, was moderated by Mitchell Clark, MD, MPH.

The presenters were:

  • Johanna D’Addario, MHS: “Genetics, Health, Wellness, and Cancer Prevention”
  • Steven Fleischman, MD, MBA: “Role of Ob/Gyn in Managing Obesity”
  • Sangini Sheth, MD, MPH: “CIN 2, 3: THINC Trial Results”
  • Mary Jane Minkin, MD: “Menopause Management After Cancer Therapy”

Session 2, on Uterine Malignancies, was moderated by Elena Ratner, MD, MBA.

The presenters were:

  • Clare Flannery, MD: “Hormones in the Development of Endometrial Cancer”
  • Masoud Azodi, MD: “Atypical Complex Hyperplasia, Is It Yours or Mine?”
  • Pei Hui, MD, PhD: “Yale Center for the Precision Medicine of Trophoblastic Disease”

In Photos: the Yale Cancer Center and Smilow Cancer Hospital's 39th Annual Ella T. Grasso Memorial Conference in Gynecologic Oncology

Session 3, on Advances in Therapy, was moderated by Katyayani Papatla, MD, MPH.

The presenters were:

  • Alessandro Santin, MD: “Antibody and Antibody Drug Conjugate in Uterine Cancer: From Bench to Bedside”
  • Melinda Irwin, PhD, MPH: “TEAL Trial on Exercise and Lifestyle in Women with Ovarian Cancer.”

Article outro

Tags

Media Contact

For media inquiries, please contact us.

Explore More

Featured in this article